Notice to Extend the Response Date for NOT-AR-22-023 "Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029"
Notice NOT-AR-23-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 17, 2022 Category: Research Source Type: funding

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Funding Opportunity PAR-23-032 from the NIH Guide for Grants and Contracts. Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 26, 2022 Category: Research Source Type: funding

Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029
Notice NOT-AR-22-023 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 6, 2022 Category: Research Source Type: funding

Notice of Correction of PAR-21-030, "Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)"
Notice NOT-AR-21-022 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 15, 2021 Category: Research Source Type: funding

Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional)
Funding Opportunity RFA-AR-21-015 from the NIH Guide for Grants and Contracts. Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional) (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 31, 2021 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases and Sjogrens Syndrome (UC2 Clinical
Notice NOT-AR-21-013 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 25, 2021 Category: Research Source Type: funding

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
Funding Opportunity PAR-21-045 from the NIH Guide for Grants and Contracts. Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 13, 2020 Category: Research Source Type: funding

Introducing the Stephen I. Katz Early Stage Investigator Research Grant Program
Stephen I. Katz, M.D., Ph.D. Stephen I. Katz, M.D., Ph.D., led the National Institute of Arthritis and Musculoskeletal Diseases from 1995 until his passing in 2018. Dr. Katz was a talented physician scientist, NIH leader, and civil servant throughout his career who was profoundly dedicated to mentoring and training the next cadre of scientists. During his memorial service at NIH, you can see this dedication on full display. I, along with countless NIH colleagues, were blessed with Dr. Katz’s mentoring and sage advice. That is why, in his honor, we are pleased to announce the publication of Funding Opportunity Announcemen...
Source: NIH Extramural Nexus - November 9, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike funding opportunities funding opportunity announcement Source Type: funding

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Funding Opportunity PAR-21-030 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that translate technology innovations from academic and other non-profit research sectors to the marketplace to advance the development of diagnostic and prevention tools or treatments for musculoskeletal, rheumatic or skin diseases. It supports pre-clinical research and development, such as moving products towards regulatory approval for clinical testing or making the new lab technologies more pra...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 8, 2020 Category: Research Source Type: funding

Institute and Center Award Rates and Funding Disparities
In 2011, Ginther et al. first demonstrated that African American and Black applicants to the National Institutes of Health received grant awards at a lower rate than their white counterparts (Ginther 2011). Since then, multiple studies have reproduced and extended this finding (Ginther 2011; Ginther 2016; Hoppe 2019; Erosheva 2020). Recently we reported that African American and Black (AAB) PIs are more likely to propose research on topics that are less likely  to be funded (Hoppe 2019). We found that topic choice has little or no effect on whether an application is chosen for discussion, but after consideri...
Source: NIH Extramural Nexus - August 12, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike Funding data Source Type: funding

NIAMS Rheumatic Diseases Research Resource-based Centers (P30- Clinical Trial Not Allowed)
Funding Opportunity RFA-AR-21-002 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 6, 2020 Category: Research Source Type: funding

NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed)
Funding Opportunity RFA-AR-21-004 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 10, 2020 Category: Research Source Type: funding

NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
Funding Opportunity RFA-AR-21-003 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for skin biology and diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on skin biology and diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2020 Category: Research Source Type: funding

Notice to Extend the Response Date for NOT-AR-19-039 "Request for Information (RFI) on the Lessons Learned from the Accelerating Medicines Partnership Rheumatoid Arthritis and Lupus (AMP RA/SLE Program)"
Notice NOT-AR-20-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 28, 2019 Category: Research Source Type: funding

Notice to Extend the Response Date for NOT-AR-19-039 "Request for Information (RFI) on the Lessons Learned from the Accelerating Medicines Partnership Rheumatoid Arthritis and Lupus (AMP RA/SLE Program)"
Notice NOT-AR-20-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 3, 2019 Category: Research Source Type: funding